2012-02-10 04:03:47 - Fast Market Research recommends "Esophageal Cancer - Pipeline Review, H1 2012" from Global Markets Direct, now available

Esophageal Cancer - Pipeline Review, H1 2012

Summary

Global Markets Direct's, 'Esophageal Cancer - Pipeline Review, H1 2012', provides an overview of the Esophageal Cancer therapeutic pipeline. This report provides information on the therapeutic development for Esophageal Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Esophageal Cancer. 'Esophageal Cancer - Pipeline Review, H1 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Note*: Certain sections in the report may be removed or altered based on the availability

and relevance of data for the indicated disease.

Scope

* A snapshot of the global therapeutic scenario for Esophageal Cancer.
* A review of the Esophageal Cancer products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
* Coverage of products based on various stages of development ranging from discovery till registration stages.
* A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
* Coverage of the Esophageal Cancer pipeline on the basis of route of administration and molecule type.
* Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
* Key discontinued pipeline projects.
* Latest news and deals relating to the products.


Full Report Details at
- www.fastmr.com/prod/330096_esophageal_cancer_pipeline_review_h1_ ..


Reasons to buy

* Identify and understand important and diverse types of therapeutics under development for Esophageal Cancer.
* Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
* Plan mergers and acquisitions effectively by identifying players with the most promising pipeline.
* Devise corrective measures for pipeline projects by understanding Esophageal Cancer pipeline depth and focus of Esophageal Cancer therapeutics.
* Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
* Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Esophageal Cancer Overview
Therapeutics Development
An Overview of Pipeline Products for Esophageal Cancer
Esophageal Cancer Therapeutics under Development by Companies
Esophageal Cancer Therapeutics under Investigation by Universities/Institutes
Late Stage Products
Comparative Analysis
Mid Clinical Stage Products
Comparative Analysis
Early Clinical Stage Products
Comparative Analysis
Discovery and Pre-Clinical Stage Products
Comparative Analysis
Esophageal Cancer Therapeutics - Products under Development by Companies
Esophageal Cancer Therapeutics - Products under Investigation by Universities/Institutes
Companies Involved in Esophageal Cancer Therapeutics Development
Bristol-Myers Squibb Company
Shionogi & Co., Ltd.
Eli Lilly and Company
GlaxoSmithKline plc
Tekmira Pharmaceuticals Corp.
Daiichi Sankyo Company, Ltd
YM BioSciences Inc.
Novartis AG
Aphios Corporation
Cell Therapeutics, Inc.
Celldex Therapeutics, Inc.
Proteo, Inc.
GANYMED Pharmaceuticals AG
Ascenta Therapeutics, Inc.
Merrimack Pharmaceuticals, Inc.
Omeros Corporation
PharmaMar, S.A.
ImmunoFrontier, Inc.
Mebiopharm Co., Ltd.
Eurofarma
Biotech Pharmaceuticals Co., Ltd.
Esophageal Cancer - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Combination Products
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
Tykerb + Capecitabine + Oxaliplatin - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Cisplatin + Capecitabine + Cetuximab + Radiation Therapy - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Cisplatin + Capecitabine + Radiation Therapy - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Paclitaxel + Cisplatin + Cetuximab + Radiation Therapy - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Cetuximab + Cisplatin + Docetaxel + Radiation Therapy - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Fluorouracil + Cisplatin + Radiation Therapy - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Cisplatin + Capecitabine + Cetuximab + Radiation Therapy - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Fluorouracil + Cisplatin + Epirubicin + Radiation Therapy - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Cisplatin + Epirubicin + Fluorouracil - Drug Profile
Product Description
Mechanism of Action
R&D Progress
TheraCIM - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Esomeprazole + Aspirin - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Cisplatin + 5-Fluorouracil + Radiation Therapy - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Lobaplatin + 5-Fluorouracil + Leucovorin - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Iressa - Drug Profile
Product Description
Mechanism of Action

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=330096&dt=t

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.